Target Name: PKP4
NCBI ID: G8502
Review Report on PKP4 Target / Biomarker Content of Review Report on PKP4 Target / Biomarker
PKP4
Other Name(s): catenin 4 | p0071 | Plakophilin-4 | PKP4 variant 1 | plakophilin 4 | Plakophilin-4 (isoform a) | PKP4_HUMAN | Plakophilin 4, transcript variant 1 | Catenin 4

PKP4: A Protein Involved in Cell Signaling and Cytoskeletal Organization

PKP4 (Catenin 4) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the superfamily of actinin-associated proteins (SAP), which are involved in cell signaling and cytoskeletal organization. While the exact function of PKP4 is not yet well understood, research has shown that it plays a role in several physiological processes, including cell migration, invasion, and metastasis.

One of the key functions of PKP4 is its role in cell signaling. It is involved in the regulation of several intracellular signaling pathways, including the TGF-β pathway, which is involved in cell growth, differentiation, and survival. PKP4 has been shown to play a negative role in the TGF-β pathway, by inhibiting the activity of the transcription factor SMAD2. This negative regulation of SMAD2 allows PKP4 to prevent excessive cell proliferation and promote cell differentiation.

Another function of PKP4 is its role in cell adhesion. It is involved in the formation of tight junctions, which are specialized junctions that are responsible for maintaining the integrity of the intercellular space. PKP4 has been shown to play a role in the regulation of tight junction formation by interacting with the protein Zonl1. This interaction between PKP4 and Zonl1 allows PKP4 to regulate the movement of proteins into the cell, which is important for maintaining the integrity of the tight junction.

In addition to its role in cell signaling and adhesion, PKP4 is also involved in the regulation of cell migration and invasion. It has been shown to play a role in the regulation of the migration of cancer cells through the regulation of the migration protein ACF2. PKP4 has also been shown to play a role in the regulation of cell invasion, by interacting with the protein N-cadherin. This interaction between PKP4 and N-cadherin allows PKP4 to regulate the movement of cells into new tissues.

The potential drug target for PKP4 is its role in cell signaling and its involvement in several physiological processes. PKP4 has been shown to play a negative role in the TGF-β pathway, which is involved in cell growth, differentiation, and survival. It is also involved in the regulation of cell adhesion and the regulation of cell migration and invasion. This suggests that PKP4 may be a useful drug target for the treatment of various diseases, including cancer.

In conclusion, PKP4 is a protein that is expressed in various tissues throughout the body, and it plays a role in several physiological processes, including cell signaling, adhesion, and migration. The potential drug target for PKP4 is its role in the regulation of cell signaling and its involvement in the TGF-β pathway. Further research is needed to fully understand the function of PKP4 and its potential as a drug target.

Protein Name: Plakophilin 4

Functions: Plays a role as a regulator of Rho activity during cytokinesis. May play a role in junctional plaques

The "PKP4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PKP4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PKP4-AS1 | PLA1A | PLA2G10 | PLA2G12A | PLA2G12AP1 | PLA2G12B | PLA2G15 | PLA2G1B | PLA2G2A | PLA2G2C | PLA2G2D | PLA2G2E | PLA2G2F | PLA2G3 | PLA2G4A | PLA2G4B | PLA2G4C | PLA2G4D | PLA2G4E | PLA2G4F | PLA2G5 | PLA2G6 | PLA2G7 | PLA2R1 | PLAA | PLAAT1 | PLAAT2 | PLAAT3 | PLAAT4 | PLAAT5 | PLAC1 | PLAC4 | PLAC8 | PLAC8L1 | PLAC9 | PLAC9P1 | PLAG1 | PLAGL1 | PLAGL2 | Plasma Membrane Calcium ATPase | PLAT | Platelet Glycoprotein Ib Complex | Platelet-activating factor acetylhydrolase isoform 1B complex | Platelet-Derived Growth Factor (PDGF) | Platelet-Derived Growth Factor Receptor | PLAU | PLAUR | PLB1 | PLBD1 | PLBD1-AS1 | PLBD2 | PLCB1 | PLCB2 | PLCB3 | PLCB4 | PLCD1 | PLCD3 | PLCD4 | PLCE1 | PLCE1-AS2 | PLCG1 | PLCG1-AS1 | PLCG2 | PLCH1 | PLCH2 | PLCL1 | PLCL2 | PLCXD1 | PLCXD2 | PLCXD3 | PLCZ1 | PLD1 | PLD2 | PLD3 | PLD4 | PLD5 | PLD6 | PLEC | PLEK | PLEK2 | PLEKHA1 | PLEKHA2 | PLEKHA3 | PLEKHA4 | PLEKHA5 | PLEKHA6 | PLEKHA7 | PLEKHA8 | PLEKHA8P1 | PLEKHB1 | PLEKHB2 | PLEKHD1 | PLEKHF1 | PLEKHF2 | PLEKHG1 | PLEKHG2 | PLEKHG3 | PLEKHG4 | PLEKHG4B | PLEKHG5